iDose implant for open-angle glaucoma
Part of Eyes & vision clinical trials.
This study tests a tiny implant, called iDose, that is placed in the eye during a short office procedure to help lower eye pressure in people with open-angle glaucoma or high pressure in the eye (ocular hypertension). It may offer a way to manage pressure without daily eye drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of open-angle glaucoma or high pressure in the eye (ocular hypertension).
- You have not had this implant before and have not had an experimental implant in the study eye.
- You do not have an active eye infection or inflammation.
- You are not allergic to travoprost or the implant materials.
- You have not had recent eye surgery.
- You do not have severe or uncontrolled health conditions that would make surgery risky.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a tiny implant called iDose® TR, placed during cataract surgery, can better control eye pressure in people with glaucoma or high eye pressure compared to cataract surgery alone.
This trial is testing a new way to deliver a medication (travoprost) directly into the eye using a small implant. It's for people with open-angle glaucoma and aims to see how well the updated inserter works.
This trial tests an investigational drug called REGN22530 for people with mild to moderate primary open-angle glaucoma or ocular hypertension (high eye pressure). The goal is to see if it can safely lower eye pressure and protect vision.
This trial tests a new implant that releases medicine for glaucoma while you have cataract surgery. It may help lower eye pressure without using daily drops.
This trial tests if a bimatoprost implant placed during cataract surgery (combined with a special lens) can lower eye pressure better than standard timolol eye drops. It may help people with mild to moderate glaucoma or high eye pressure who are already planning cataract surgery.
This trial studies a new treatment (a tiny device called iStent Infinite and a medication implant) for people with moderate to severe open-angle glaucoma who have not responded well to drops or laser. The goal is to see if this treatment can lower eye pressure and help avoid traditional surgery.
Hear when a new Ocular Hypertension (OHT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.